NO20010882L - Terapier for behandling av lungesykdommer - Google Patents

Terapier for behandling av lungesykdommer

Info

Publication number
NO20010882L
NO20010882L NO20010882A NO20010882A NO20010882L NO 20010882 L NO20010882 L NO 20010882L NO 20010882 A NO20010882 A NO 20010882A NO 20010882 A NO20010882 A NO 20010882A NO 20010882 L NO20010882 L NO 20010882L
Authority
NO
Norway
Prior art keywords
therapies
treatment
lung diseases
lung
diseases
Prior art date
Application number
NO20010882A
Other languages
English (en)
Other versions
NO20010882D0 (no
Inventor
Richard Nieman
Anthony S Rebuck
Theodore J Torphy
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20010882L publication Critical patent/NO20010882L/no
Publication of NO20010882D0 publication Critical patent/NO20010882D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20010882A 1998-08-26 2001-02-21 Terapier for behandling av lungesykdommer NO20010882D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9797398P 1998-08-26 1998-08-26
PCT/US1999/019332 WO2000012078A1 (en) 1998-08-26 1999-08-24 Therapies for treating pulmonary diseases

Publications (2)

Publication Number Publication Date
NO20010882L true NO20010882L (no) 2001-02-21
NO20010882D0 NO20010882D0 (no) 2001-02-21

Family

ID=22266001

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010882A NO20010882D0 (no) 1998-08-26 2001-02-21 Terapier for behandling av lungesykdommer

Country Status (21)

Country Link
US (2) US6288118B1 (no)
EP (1) EP1107747A4 (no)
JP (1) JP2002523452A (no)
KR (1) KR20010072931A (no)
CN (1) CN1314811A (no)
AR (1) AR022072A1 (no)
AU (1) AU754379B2 (no)
BR (1) BR9913152A (no)
CA (1) CA2341488A1 (no)
CZ (1) CZ293735B6 (no)
DZ (1) DZ2876A1 (no)
HU (1) HUP0103160A3 (no)
IL (1) IL141335A0 (no)
MA (1) MA26302A1 (no)
MY (1) MY126544A (no)
NO (1) NO20010882D0 (no)
NZ (1) NZ527232A (no)
PE (1) PE20001032A1 (no)
PL (1) PL346271A1 (no)
TR (1) TR200100500T2 (no)
WO (1) WO2000012078A1 (no)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525018B1 (en) * 1999-05-17 2003-02-25 The General Hospital Corp. Treating eye disorders using intestinal trefoil proteins
US6624181B1 (en) 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
US20030185838A1 (en) * 2001-11-28 2003-10-02 Podolsky Daniel K. Methods and compositions for treating lesions of the respiratory epithelium
US20030186882A1 (en) * 2001-07-31 2003-10-02 Podolsky Daniel K. Methods and compositions for treating and preventing distal bowel lesions
CA2341488A1 (en) * 1998-08-26 2000-03-09 Smithkline Beecham Corporation Therapies for treating pulmonary diseases
US8933032B2 (en) 1998-10-20 2015-01-13 Children's Hospital Medical Center Surfactant protein D for the treatment of disorders associated with lung injury
PL200923B1 (pl) * 1999-08-21 2009-02-27 Nycomed Gmbh Lek zawierający inhibitor PDE w połączeniu z agonistą receptoraß₂ -adrenergicznego oraz zastosowanie połączenia roflumilastu i salmeterolu
CN1471515A (zh) 2000-06-05 2004-01-28 ��̹��ҽҩ��˾ 作为β2-肾上腺素受体激动剂及PDE-4抑制剂的有效的化合物
US20040171544A1 (en) * 2001-04-24 2004-09-02 Barker Nicholas P. Trefoil domain-containing polypeptides and uses thereof
US20030105016A1 (en) * 2001-09-06 2003-06-05 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
US7538082B2 (en) 2001-04-24 2009-05-26 The General Hospital Corporation Methods and compositions for treating oral and esophageal lesions
US20060189526A1 (en) * 2002-04-24 2006-08-24 Podolsky Daniel K Compositions containing an intestinal trefoil peptide and a mucoadhesive
US20030186880A1 (en) * 2002-03-26 2003-10-02 Podolsky Daniel K. Combination therapy using trefoil peptides
US20030181384A1 (en) * 2001-09-06 2003-09-25 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
JP2005508937A (ja) * 2001-10-05 2005-04-07 ザ ジェネラル ホスピタル コーポレーション 皮膚病変を治療するための方法および組成物
US20030185839A1 (en) * 2001-10-05 2003-10-02 Podolsky Daniel K. Methods and compositions for treating dermal lesions
US7931022B2 (en) * 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
AU2002351181B2 (en) * 2001-11-28 2008-08-07 The General Hospital Corporation Methods and compositions for treating lesions of the respiratory epithelium
GB0129395D0 (en) * 2001-12-07 2002-01-30 Pfizer Ltd Pharmaceutical combination
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
DE10220459A1 (de) * 2002-05-07 2003-11-27 Byk Gulden Lomberg Chem Fab Neue Kombination zur Behandlung von Atemwegserkrankungen
DE10220458A1 (de) * 2002-05-07 2003-11-27 Altana Pharma Ag Kombination zur Behandlung von Atemwegserkrankungen
WO2003094967A2 (en) * 2002-05-07 2003-11-20 Altana Pharma Ag New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders
NZ536918A (en) * 2002-05-07 2006-09-29 Altana Pharma Ag Combination of pantoprazole and a respiratory agent for the treatment of respiratory diseases
US20060188471A1 (en) * 2002-10-31 2006-08-24 Podolsky Daniel K Methods of treating epithelial lesions
DE60321954D1 (de) * 2002-11-27 2008-08-14 Nycomed Gmbh Synergistische zusammensetzung enthaltend roflumilast und (r,r)-formoterol
DK1567139T3 (da) * 2002-11-27 2008-11-03 Nycomed Gmbh Hidtil ukendt synergistisk kombination der omfatter roflumilast og formoterol
EA009985B1 (ru) 2003-03-10 2008-04-28 Никомед Гмбх Новый способ получения рофлумиласта
JPWO2004087151A1 (ja) * 2003-03-31 2006-06-29 協和醗酵工業株式会社 医薬組成物
SE527200C2 (sv) * 2003-06-19 2006-01-17 Microdrug Ag Inhalatoranordning samt kombinerade doser av formaterol och fluticason
WO2005123072A1 (en) * 2004-06-14 2005-12-29 Sepracor Inc. Methods and compositions for the treatment of pulmonary diseases
JP2008502698A (ja) * 2004-06-14 2008-01-31 セプラコール・インコーポレイテッド アルブテロール、及びカルシウム活性化カリウムチャネルオープナーの使用方法。
ES2421916T3 (es) 2005-03-16 2013-09-06 Nycomed Gmbh Forma farmacéutica de sabor enmascarado que contiene roflumilast
DE102005030733A1 (de) * 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
CA2682730A1 (en) * 2007-04-11 2008-10-23 Alcon Research, Ltd. Use of an inhibitor of tnf.alpha. plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
CN107243076A (zh) * 2009-04-22 2017-10-13 印第安那大学科技研究公司 用于治疗慢性阻塞性肺病和哮喘的组合物和方法
US20110082145A1 (en) * 2009-10-01 2011-04-07 Alcon Research, Ltd. Olopatadine compositions and uses thereof
KR101035488B1 (ko) * 2009-10-05 2011-05-20 숭실대학교산학협력단 자동차 블랙박스 영상물 수집 방법
WO2011056561A1 (en) 2009-10-27 2011-05-12 Beth Israel Deaconess Medical Center Methods and compositions for the generation and use of conformation-specific antibodies
US8394829B2 (en) 2010-05-10 2013-03-12 Gilead Sciences, Inc. Bi-functional quinoline analogs
WO2011143106A1 (en) 2010-05-10 2011-11-17 Gilead Sciences, Inc. Bi - functional pyrazolopyridine compounds
US10487114B2 (en) 2011-04-27 2019-11-26 Beth Israel Deaconess Medical Center, Inc. Methods for administering peptides for the generation of effective c/s conformation-specific antibodies to a human subject in need thereof
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof
US10433624B2 (en) * 2015-03-26 2019-10-08 Nike, Inc. Duffel bag
US11866482B2 (en) 2018-02-07 2024-01-09 Duke University System and method for homogenous GPCR phosphorylation and identification of beta-2 adrenergic receptor positive allosteric modulators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791025A (fr) 1971-11-19 1973-05-07 Allen & Hanburys Ltd Composes heterocycliques
GB1457873A (en) 1973-01-04 1976-12-08 Allen & Hanburys Ltd Imidazotriazines
FR2390164A1 (fr) 1977-05-13 1978-12-08 Blanie Paul Association a action anti-asthmatique
US5602110A (en) 1994-08-31 1997-02-11 Case Western Reserve University Method and composition for treating cystic fibrosis
FR2753706B1 (fr) * 1996-09-20 1998-10-30 Nouvelles amines cycliques n-substituees, leur procede de preparation et les compositions pharmaceutiques les renfermant
FR2753969B1 (fr) * 1996-09-27 1998-10-30 Adir Nouveaux derives de flavones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PT975347E (pt) * 1997-02-28 2008-05-23 Nycomed Gmbh Combinação sinérgica de inibidores da pde e agonistas da adenilato ciclase ou agonistas da guanil ciclise
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
CA2341488A1 (en) * 1998-08-26 2000-03-09 Smithkline Beecham Corporation Therapies for treating pulmonary diseases

Also Published As

Publication number Publication date
AU5493999A (en) 2000-03-21
JP2002523452A (ja) 2002-07-30
CZ2001692A3 (cs) 2002-02-13
CZ293735B6 (cs) 2004-07-14
AU754379B2 (en) 2002-11-14
PE20001032A1 (es) 2000-11-10
HUP0103160A3 (en) 2002-11-28
EP1107747A4 (en) 2003-04-23
IL141335A0 (en) 2002-03-10
KR20010072931A (ko) 2001-07-31
CN1314811A (zh) 2001-09-26
EP1107747A1 (en) 2001-06-20
HUP0103160A2 (hu) 2002-01-28
WO2000012078A1 (en) 2000-03-09
MY126544A (en) 2006-10-31
DZ2876A1 (fr) 2003-12-15
US6555583B2 (en) 2003-04-29
US20010056122A1 (en) 2001-12-27
MA26302A1 (fr) 2004-10-01
TR200100500T2 (tr) 2001-06-21
NO20010882D0 (no) 2001-02-21
US6288118B1 (en) 2001-09-11
CA2341488A1 (en) 2000-03-09
PL346271A1 (en) 2002-01-28
NZ527232A (en) 2005-03-24
BR9913152A (pt) 2001-05-15
AR022072A1 (es) 2002-09-04

Similar Documents

Publication Publication Date Title
NO20010882D0 (no) Terapier for behandling av lungesykdommer
NO20012995L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
NO965377L (no) Indolinonforbindelser for behandling av sykdommer
NO995221D0 (no) Sulfonamider for behandling av endotelinmedierte sykdommer
DE69734513D1 (de) Phenylamino-substituierte triicyclische derivate zur behandlung hyperproliferativer krankheiten
FI952721A7 (fi) Aine maksa-sappi-sairauksien hoitamiseksi
FI971568A0 (fi) Menetelmä resistenttien kasvainten hoitamiseksi
NO20005884D0 (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
ATE262331T1 (de) Heterocyclische vinylether zur behandlung neurologischer krankheiten
ATE246500T1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen erkrankungen der atemwege
EE200300214A (et) Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks
ATE271038T1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
NO20005885D0 (no) Kombinasjonsterapi for behandling av refraktær depresjon
NO990722D0 (no) FremgangsmÕte for behandling av hjertesvikt
GB0004531D0 (en) The treatment of respiratory diseases
FI971527L (fi) Indolijohdannaisten käyttö erilaisten sairauksien hoitoon
EP1039883A4 (en) METHOD FOR TREATING APOLIPOPROTEIN E CONDITIONAL DISEASES
ATE261434T1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
NO20020784D0 (no) Medikament for behandling av brudd
EE03437B1 (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
NO991164D0 (no) Farmas°ytisk preparat for behandling av virussykdommer
AU3004000A (en) Methods for the treatment of apolipoprotein e related diseases
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO20002481D0 (no) Kombinasjonsterapi for behandling av AIDS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application